JaLCDOI 10.18926/AMO/30816
フルテキストURL fulltext.pdf
著者 Orita, Kunzo| Miwa, Hiroaki| Mannami, Tetsuya| Konaga, Eiji| Yumura, Masahito| Fukuda, Hanzo| Uchida, Yoshio| Nakahara, Harutsugu| Hayashi, Shigeo|
抄録 <p>With the recent advances in the immunological surveillance system, an understanding of the role of host immunity has become essential to the management of carcinogenesis, tumor proliferation, recurrence and metastasis. Although it is important to continue chemical and surgical treatment of cancer, support of the anti-tumor immune system of the host should also be considered. Long term remission has been reported in leukemia by treating with BCG after chemotherapy whereas surgical treatment is usually more effective in preventing cancer recurrence in digestive organ cancer. The first step is extirpating the tumor as thoroughly as possible and the second step is chemo-immunotherapy. Cancer immunity, however weak, constitutes the basis for other treatments in selectively attacking cancer cells remaining after surgery, chemotherapy or irradiation. Immunotherapy should thus not replace chemotherapy or radiotherapy, but these methods should be employed in combination to attain more favorable results.</p>
Amo Type Review
発行日 1977-08
出版物タイトル Acta Medica Okayama
31巻
4号
出版者 Okayama University Medical School
開始ページ 217
終了ページ 234
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 English
論文のバージョン publisher
査読 有り
PubMed ID 145159
NAID 120002305634